Ftse Mib
33.315,68
0,00%
DAX
18.123,58
0,00%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
65.536,00
0,61%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Genetic Technologies Ltd (GENE) Genetic Technologies Ltd (GENE) Notizie

Genetic Technologies Ltd

GENE
1,72
0,02 (1,18%)
18 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/6/202414:00GLOBEGenetic Technologies Expands Operational Capacity in North..
05/6/202414:00GLOBEGeneType and Stayhealthy Announce Landmark Distribution..
05/6/202412:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/5/202414:00GLOBEGTG Launches Revolutionary geneType Test covering 100% Risk..
29/5/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
23/5/202414:00GLOBEGeneType and Humanise Health host “Know Your Risk” Event
06/5/202414:00GLOBEGTG and ‘Wellworks for You’ sign B2B sales & marketing deal..
22/4/202421:00GLOBEGenetic Technologies Announces Closing of US$2 Million..
18/4/202418:17GLOBEGenetic Technologies Announces $2 Million Registered Direct..
17/4/202414:00GLOBENew Precision Oncology Tests to Drive Personalised Therapies..
16/4/202414:00GLOBEGeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year..
11/4/202414:00GLOBEGTG to pilot GeneType in Breast Screen centers across the..
08/4/202414:00GLOBEEVENT - Empowering Women Through Knowledge; Humanise Health..
02/4/202414:05GLOBEGenetic Technologies’ Digital Strategy Ignites Significant..
26/3/202413:00GLOBEGTG Global Collaborations and Innovation Update
25/3/202413:00GLOBEGENE to develop Worlds Most Advanced Comprehensive Risk Test..
26/2/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202420:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202414:00GLOBELaunching our most comprehensive test and expanding into new..
09/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202414:00GLOBEGenetic Technologies Regains Compliance with Nasdaq Minimum..
28/12/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202323:00EDGAR2Form F-3 - Registration statement by foreign private issuers
14/12/202314:00GLOBEGeneType's Groundbreaking Saliva Test Transforms Early..
12/12/202314:00GLOBEGenetic Technologies Limited Announces Ordinary Share..
30/10/202313:00GLOBEGene Business Update: Private Hospital Partnership; Expanded..
18/10/202314:30GLOBEGeneType Predicting Risk of Pancreatic Cancer: Major..
27/9/202315:00GLOBEGTG Signs Precision Medicine Pilot with Australia’s Largest..
12/9/202314:00GLOBEBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and..
11/9/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202314:30GLOBEGENE Positioned at the Forefront of Multi-cancer Clinical..
11/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202316:00GLOBEGenetic Technologies Limited and 60 Degrees Pharmaceuticals..
30/8/202314:45GLOBEAnnual Results – Momentum Building on our Commercial Plans
09/8/202314:00GLOBEGenetic Technologies Limited Announces Updated Investor..
28/7/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/7/202314:00GLOBEQuarterly Activities Update: Encouraging Growth for geneType..
21/7/202314:00GLOBEGenetic Technologies Receives Nasdaq Notification Regarding..
Apertura: 1,70 Min: 1,615 Max: 1,79
Chiusura: 1,70

La tua Cronologia

NASDAQ
GENE
Genetic Technologies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network